go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

Gerard Laboratories

Gerard Laboratories
Unit 36, Baldoyle Industrial Estate, Grange Road, Baldoyle, Dublin 13,
Telephone: +353 1 832 2250
Fax: +353 1 466 1912
Medical Information Direct Line: +353 1800 272 272
Medical Information e-mail: sales@gerard-laboratories.ie
Summary of Product Characteristics last updated on medicines.ie: 08/12/2011
SPC Amlist 5mg & 10mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 08/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.9 - Overdose
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   27-Jul-2011
Legal Category:   Product subject to medical prescription which may be renewed (B)

Free-text change information supplied by the pharmaceutical company

Extensive changes to update product information with recommended wording from CSP and Article 45.
Updated on 14/11/2008 and displayed until 08/12/2011
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 6.3 - Shelf life
  • Change to section 6.4 - Special precautions for storage
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   09/2008
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Amlodipine 5 mg tablets:

Each tablet contains 5 mg of amlodipine (as amlodipine maleate).

Excipient(s): 151.60 mg Lactose monohydrate

Amlodipine 10 mg tablets:

Each tablet contains 10 mg of amlodipine (as amlodipine maleate).

Excipient(s): 145.20 mg Lactose monohydrate

For a full list of excipients, see Section 6.1.

3. PHARMACEUTICAL FORM

Tablet.

5 mg tablets: White round tablets.

10 mg tablets: White, round tablets with a break score on both sides. The tablet can be divided into

equal halves.

4.4 Special warnings and precautions for use

Patients with lactose intolerance

Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-

galactose malabsorption should not take this medicine.

4.8 Undesirable effects

Musculoskeletal and connective tissue and bone disorders

Uncommon: Muscle cramps, back pain, myalgia and arthralgia.

6.3 Shelf life

Amlodipine 5 mg tablets: 24 months. 2 years

Amlodipine 10 mg tablets: 36 months. 3 years

6.4 Special precautions for storage

Amlodipine 5 mg tablets: Do not store above 25°C. Store in the original package in order to protect

from moisture.

Amlodipine 10 mg tablets: Do not store above 30°C. Store in the original package in order to protect

from moisture.

Updated on 15/06/2007 and displayed until 14/11/2008
Reasons for adding or updating:
  • Change to section 6.4 - Special precautions for storage
Date of revision of text on the SPC:   05/2007
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company

5mg Tablets section 6.4: changed to do not store above 25oC. Store in the original pack.

Updated on 07/03/2007 and displayed until 15/06/2007
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 16/08/2005 and displayed until 07/03/2007
Reasons for adding or updating:
  • New SPC for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   amlodipine maleate

Versions

 
08/12/2011 to Current
14/11/2008 to 08/12/2011
15/06/2007 to 14/11/2008
07/03/2007 to 15/06/2007
16/08/2005 to 07/03/2007
  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo